表紙
市場調査レポート

糖尿病性末梢神経障害:世界の治験レビュー

Diabetic Peripheral Neuropathy Global Clinical Trials Review, H1, 2014

発行 GlobalData 商品コード 302385
出版日 ページ情報 英文 127 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
糖尿病性末梢神経障害:世界の治験レビュー Diabetic Peripheral Neuropathy Global Clinical Trials Review, H1, 2014
出版日: 2014年05月15日 ページ情報: 英文 127 Pages
概要

当レポートでは、糖尿病性末梢神経障害に関する臨床研究の最新動向について分析し、疾患・治療法の概要や、主な先進国・新興国における治験の状況、地域・フェーズ(相)・段階別の進行状況、有望なスポンサー、各企業・研究機関での研究の進行状況、有望な薬剤などの情報を盛り込んで、概略以下の構成でお届けします。

目次

イントロダクション

  • 糖尿病性末梢神経障害
  • 当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • アジア太平洋地域の主要5ヶ国
    • 欧州の主要5ヶ国
    • 北米の主要国
    • 中東・アフリカの主要5ヶ国
    • 中南米の主要5ヶ国

G7諸国での治験件数:代謝性疾患治験全体における糖尿病性末梢神経障害の割合

G7諸国での治験件数:フェーズ(相)別

G7諸国での治験件数:進捗状況別

E7諸国での治験件数:代謝性疾患治験全体における糖尿病性末梢神経障害の割合

E7諸国での治験件数:フェーズ(相)別

E7諸国での治験件数:進捗状況別

フェーズ(相)別の治験件数

  • 進行中の治験:フェーズ別

進捗状況別の治験件数

一定期間に採用された被験者

スポンサーの種類別の治験件数

有望なスポンサー

  • 糖尿病性末梢神経障害治療薬の治験に参加している上位企業

有望な薬剤

治験のプロファイル

  • 代表的企業の治験の概要
    • Pfizer Inc.
    • Eli Lilly and Company
    • Nestle Health Science S.A.
    • 武田薬品工業
    • Grunenthal GmbH
    • 第一三共
    • アステラス製薬
    • SK Biopharmaceuticals Co., Ltd.
    • Johnson & Johnson
    • C. H. Boehringer Sohn AG & Co. KG
  • 代表的な研究機関・病院の治験の概要
    • University of Michigan
    • Hamedan University of Medical Sciences
    • Inha University Hospital
    • Joslin Diabetes Center
    • The University of Melbourne
    • University of Surrey
    • Loma Linda University
    • Islamic Azad University of Tabriz
    • University of Missouri
    • University of Calgary

5つの代表的な治験のプロファイル

付録

図表一覧

目次
Product Code: GDHC2133CTIDB

GlobalData's clinical trial report, "Diabetic Peripheral Neuropathy Global Clinical Trials Review, H1, 2014" provides data on the Diabetic Peripheral Neuropathy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diabetic Peripheral Neuropathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Diabetic Peripheral Neuropathy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Diabetic Peripheral Neuropathy
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Diabetic Peripheral Neuropathy to Metabolic Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Diabetic Peripheral Neuropathy to Metabolic Disorders Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Diabetic Peripheral Neuropathy
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Diabetic Peripheral Neuropathy Therapeutics Clinical Trials
  • Prominent Drugs
  • Latest Clinical Trials News on Diabetic Peripheral Neuropathy
    • Oct 18, 2013: Pfizer Reports Top-Line Results From Two Lyrica Capsules CV Phase 3b Studies
    • Nov 27, 2012: Intellipharmaceutics Announces Results Of Initial Phase I Clinical Trial Of Controlled-release Pregabalin
    • Aug 29, 2012: RegeneRx Reports That Thymosin Beta 4 Promotes Recovery Of Peripheral Neuropathy In Type II Diabetic Mice
    • May 04, 2012: Pfizer Reports Top-Line Results From Phase III Trial Of Lyrica Capsules CV In Patients With Diabetic Peripheral Neuropathy
    • Feb 21, 2012: SK Biopharmaceuticals Initiates Phase II Trials In US
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Eli Lilly and Company
      • Clinical Trial Overview of Eli Lilly and Company
      • Nestle Health Science S.A.
      • Clinical Trial Overview of Nestle Health Science S.A.
      • Takeda Pharmaceutical Company Limited
      • Clinical Trial Overview of Takeda Pharmaceutical Company Limited
      • Grunenthal GmbH
      • Clinical Trial Overview of Grunenthal GmbH
      • Daiichi Sankyo Company, Limited
      • Clinical Trial Overview of Daiichi Sankyo Company, Limited
      • Astellas Pharma Inc.
      • Clinical Trial Overview of Astellas Pharma Inc.
      • SK Biopharmaceuticals Co., Ltd.
      • Clinical Trial Overview of SK Biopharmaceuticals Co., Ltd.
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • C. H. Boehringer Sohn AG & Co. KG
      • Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG
    • Clinical Trial Overview of Top Institutes / Government
      • University of Michigan
      • Clinical Trial Overview of University of Michigan
      • Hamedan University of Medical Sciences
      • Clinical Trial Overview of Hamedan University of Medical Sciences
      • Inha University Hospital
      • Clinical Trial Overview of Inha University Hospital
      • Joslin Diabetes Center
      • Clinical Trial Overview of Joslin Diabetes Center
      • The University of Melbourne
      • Clinical Trial Overview of The University of Melbourne
      • University of Surrey
      • Clinical Trial Overview of University of Surrey
      • Loma Linda University
      • Clinical Trial Overview of Loma Linda University
      • Islamic Azad University of Tabriz
      • Clinical Trial Overview of Islamic Azad University of Tabriz
      • University of Missouri
      • Clinical Trial Overview of University of Missouri
      • University of Calgary
      • Clinical Trial Overview of University of Calgary
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials by Region, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014*
  • Proportion of Diabetic Peripheral Neuropathy to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014*
  • Diabetic Peripheral Neuropathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Diabetic Peripheral Neuropathy to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014*
  • Diabetic Peripheral Neuropathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials In Progress by Phase 2014*
  • Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics, Global, Suspended Clinical Trials, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics, Global, Terminated Clinical Trials, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Diabetic Peripheral Neuropathy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Nestle Health Science S.A., 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Grunenthal GmbH, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by SK Biopharmaceuticals Co., Ltd., 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Michigan, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Hamedan University of Medical Sciences, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Inha University Hospital, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Joslin Diabetes Center, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Melbourne, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Surrey, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Loma Linda University, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Islamic Azad University of Tabriz, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Missouri, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Calgary, 2014*

List of Figures

  • Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, North America, Top Countries (%), 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014*
  • Proportion of Diabetic Peripheral Neuropathy to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014*
  • Diabetic Peripheral Neuropathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Diabetic Peripheral Neuropathy to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014*
  • Diabetic Peripheral Neuropathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials In Progress by Phase, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Diabetic Peripheral Neuropathy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Global, Key Sponsors, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014*
  • Diabetic Peripheral Neuropathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014*
  • GlobalData Methodology
Back to Top